The majority of people with COVID toes — which Freeman likens to chilblains (also called pernio), an inflammatory skin condition that often occurs after exposure to very cold temperatures — don’t experience other symptoms of a coronavirus infection and don’t require hospitalization for care. “Many patients are developing these toe lesions well after their infection, or they’re otherwise completely asymptomatic, except for the toes,” she adds.
The Covid-19 virus can linger on objects for as little as a few hours or as long as a couple of days, depending on the surface. Here’s the research.
In the last two weeks of July, nearly 100,000 children in the United States tested positive for the coronavirus, according to data from the American Academy of Pediatrics and the Children’s Hospital Association.
The speed and the scale of the infections — dozens of countries have not yet recorded 100,000 cases in total — further complicate the already daunting issue of reopening schools. In Georgia, Indiana and other states, some schools that reopened have already closed down again after new outbreaks emerged.
Recent research suggests that children can carry at least as much of the virus in their noses and throats as adults do, even if they have only mild or moderate symptoms. That has prompted fears that students who become ill at school may spread the virus to their older relatives.
But it’s not just older people who are at risk — in some rare cases, a child’s health can be severely affected. Nearly 600 young people in the U.S., from infants to 20-year-olds, have developed an inflammatory syndrome linked to Covid-19, the Centers for Disease Control and Prevention reports. Most of the children required intensive care.
“I fear that there has been this sense that kids just won’t get infected or don’t get infected in the same way as adults and that, therefore, they’re almost like a bubbled population,” Michael Osterholm, an infectious disease expert at the University of Minnesota, told The Times in July.
“There will be a transmission,” he said. “What we have to do is accept that now and include that in our plans.”
While many hold out hopes for a vaccine to end the epidemic, one expert warns that vaccines are just part of the solution. Mask-wearing, shutting down some businesses, limiting large gatherings, and finding potential treatments will continue to be critical as a vaccine is still months away, and may not be completely effective even when there is one.
The coronavirus has mutated since it started spreading late last year, and a variant known as “G” is now dominant across the United States and the world. “The mutation doesn’t appear to make people sicker, but a growing number of scientists worry that it has made the virus more contagious,” our science desk wrote. Read the story to learn what makes coronavirus G different from the original version — and potentially more dangerous.
Phase 3 looks like this:
•Safer at home—especially if you are vulnerable
•No social gatherings of more than 250 individuals
•Continued social distancing
•Face coverings required in indoor public spaces
•Expanded business operations
The World Health Organization has temporarily halted studying hydroxychloroquine as a potential Covid-19 treatment in its Solidarity Trial due to safety concerns, WHO Director-General Tedros Adhanom Ghebreyesus said during a briefing in Geneva on Monday.
The decision was made after an observational study was published in the medical journal The Lancet on Friday, which described how seriously ill Covid-19 patients who were treated with hydroxychloroquine and chloroquine were more likely to die.
The CDC estimates more than a third of coronavirus patients don’t have any symptoms at all, and 40% of virus transmission happens before people feel sick. The figures are part of the agency’s new guidance for mathematical modelers and public health officials and are not supposed to be predictions of how many people could have or contract Covid-19. The CDC has also released mortality figures and scenarios intended to help public health preparedness. Under the most severe of the five scenarios outlined, the CDC lists asymptomatic case fatality ratio of 0.01, meaning that 1% of people overall with Covid-19 and symptoms would die. But some experts say the figures lowball the proportion of people who are succumbing to the disease.
Antibody tests could help scientists understand the extent of COVID-19’s spread in populations. Because of limitations in testing accuracy and a plethora of unknowns about immunity itself, however, they are less informative about an individual’s past exposure or protection against future infection.